Versigent (NYSE:VGNT) Given Consensus Rating of “Moderate Buy” by Brokerages

Versigent (NYSE:VGNT) has earned an average rating of “Moderate Buy” from the eleven ratings firms that are currently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $46.6667.

A number of equities research analysts recently weighed in on the company. Evercore restated an “outperform” rating and issued a $60.00 price target on shares of Versigent in a report on Monday, May 18th. TD Cowen boosted their target price on Versigent from $47.00 to $49.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Wolfe Research assumed coverage on Versigent in a report on Thursday, April 30th. They issued an “outperform” rating and a $53.00 target price on the stock. Fox Advisors raised Versigent to a “strong-buy” rating in a report on Tuesday, April 7th. Finally, Wells Fargo & Company raised their price target on Versigent from $35.00 to $42.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th.

Versigent Stock Down 3.2%

VGNT opened at $46.70 on Friday. The company has a 50 day simple moving average of $39.66. Versigent has a 12 month low of $26.34 and a 12 month high of $50.88.

Versigent (NYSE:VGNT) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $999.00 EPS for the quarter.